植え込み型心臓モニター市場：適応症、用途、エンドユーザー別-2025-2030年の世界予測

植え込み型心臓モニター市場は、2023年に5億8,470万米ドルと評価され、2024年には6億2,586万米ドルに達すると予測され、CAGR 7.13％で成長し、2030年には9億4,711万米ドルに達すると予測されています。

植え込み型心臓モニター（ICM）は、心臓のリズムを継続的に追跡するために使用される高度な医療機器であり、主に不整脈の検出と診断に役立ちます。ICMの必要性は、人口の高齢化、ストレスレベルの上昇、生活習慣病などの要因によって、世界中で心臓疾患の発生率が上昇していることからも明らかです。ICMは主に心房細動の診断、原因不明の脳卒中管理、原因不明の失神に応用されており、病院、心臓専門センター、外来手術センターが主なエンドユーザーです。同市場は、低侵襲手技の採用増加や、より良い患者管理とヘルスケア成果の向上を可能にするワイヤレスや遠隔モニタリング機能などの先進技術により、大幅な成長を遂げています。成長に影響を与える主な要因としては、心血管疾患の急増、心臓モニタリング機器の技術進歩、ヘルスケア支出の増加などが挙げられます。遠隔医療機能と統合されたスマートICMの探求には機会が存在し、リアルタイムでの患者モニタリングと分析を促進し、慢性疾患を積極的に管理する方法を提供します。しかし、デバイスの導入やメンテナンスにかかるコストが高く、データセキュリティや患者のプライバシーに対する懸念と相まって、普及を妨げる可能性があるなどの限界に市場は直面しています。規制状況も進化しており、この分野のプレーヤーにとってさらなる課題となっています。イノベーションは、費用対効果の高いソリューション、機器の長寿命化、堅牢なサイバーセキュリティ対策の確保とデータ接続性の強化に向けられるべきです。企業は、予測分析のためのAIを統合し、患者データをより深く理解することで、治療経路を再構築し、新たな市場ベンチマークを確立できるよう、テック企業との協業を模索すべきです。全体として、植え込み型心臓モニター市場は、満たされていない臨床ニーズが原動力となり、技術の進歩に後押しされながら、業界の戦略的対応を求める既存の障壁を抱えながら、着実な成長軌道にあります。

市場力学：急速に進化する植え込み型心臓モニター市場の主要市場インサイトを公開

植え込み型心臓モニター市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響についてより明確に理解することができます。

• 市場促進要因
  • 心血管疾患の有病率の上昇
  • ウェアラブル心臓機器への嗜好の高まり
  • 心臓疾患の治療機器や治療オプションに対する意識の高まり
• 市場抑制要因
  • ループレコーダーにかかる初期コストの高さ
• 市場機会
  • 長い検出ベクトルを持つ小型植え込み型心臓モニターの進歩
  • 長期ECGモニタリングのためのICM技術の発展
• 市場の課題
  • 心電図に精通した熟練専門家の不足

ポーターの5つの力：植え込み型心臓モニター市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：植え込み型心臓モニター市場における外部からの影響の把握

外部マクロ環境要因は、植え込み型心臓モニター市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析植え込み型心臓モニター市場における競合情勢の把握

植え込み型心臓モニター市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス植え込み型心臓モニター市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、植え込み型心臓モニター市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨植え込み型心臓モニター市場における成功への道筋を描く

植え込み型心臓モニター市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の罹患率の上昇
    • ウェアラブル心臓デバイスへの関心が高まる
    • 心臓疾患の機器と治療法に関する認識の向上
  • 抑制要因
    • ループレコーダーに関連する初期コストが高い
  • 機会
    • 長いセンシングベクトルを備えた小型化植え込み型心臓モニターの進歩
    • 長期心電図モニタリングのためのICM技術の技術開発
  • 課題
    • 心電図検査の専門知識を持つ熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 植え込み型心臓モニター市場適応症別

• 心房細動
• 不整脈
• てんかんと原因不明の転倒

第7章 植え込み型心臓モニター市場：用途別

• 心房細動
• 失神

第8章 植え込み型心臓モニター市場：エンドユーザー別

• 外来手術センター
• 心臓センターとクリニック
• 病院

第9章 南北アメリカの植え込み型心臓モニター市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の植え込み型心臓モニター市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの植え込み型心臓モニター市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Angel Medical Systems, Inc.
• BioTelemetry, Inc. by Koninklijke Philips N.V.
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Jarvik Heart, Inc.
• LivaNova PLC
• Medicomp, Inc.
• Medtronic PLC
• Oracle Corporation
• Phoenix Heart Center by Steward Medical Group
• Preventice Solutions, Inc.
• Scott Fetzer Company
• Siemens AG
• Techindia Infoway Pvt Ltd.

LIST OF FIGURES

• FIGURE 1. IMPLANTABLE CARDIAC MONITOR MARKET RESEARCH PROCESS
• FIGURE 2. IMPLANTABLE CARDIAC MONITOR MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. IMPLANTABLE CARDIAC MONITOR MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. IMPLANTABLE CARDIAC MONITOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IMPLANTABLE CARDIAC MONITOR MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IMPLANTABLE CARDIAC MONITOR MARKET DYNAMICS
• TABLE 7. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY CARDIAC ARRHYTHMIAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY EPILEPSY & UNEXPLAINED FALLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY SYNCOPE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY CARDIAC CENTERS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM IMPLANTABLE CARDIAC MONITOR MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. IMPLANTABLE CARDIAC MONITOR MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. IMPLANTABLE CARDIAC MONITOR MARKET, FPNV POSITIONING MATRIX, 2023

The Implantable Cardiac Monitor Market was valued at USD 584.70 million in 2023, expected to reach USD 625.86 million in 2024, and is projected to grow at a CAGR of 7.13%, to USD 947.11 million by 2030.

Implantable cardiac monitors (ICMs) are sophisticated medical devices used to continuously track heart rhythms, primarily aiding in the detection and diagnosis of arrhythmias. The necessity of ICMs is underscored by the rising incidence of cardiac disorders worldwide, driven by factors like aging populations, increasing stress levels, and lifestyle diseases. ICMs find applications primarily in the diagnosis of atrial fibrillation, management of cryptogenic stroke, and unexplained syncope, with hospitals, specialized cardiac centers, and ambulatory surgical centers being the primary end users. The market is witnessing substantial growth due to the increasing adoption of minimally invasive procedures and advancing technologies, such as wireless and remote monitoring capabilities, which enable better patient management and improved healthcare outcomes. Key influencing growth factors include the surge in cardiovascular diseases, technological advancements in cardiac monitoring devices, and increased healthcare spending. Opportunities exist in the exploration of smart ICMs integrated with telemedicine features to facilitate real-time patient monitoring and analytics, providing a way to proactively manage chronic conditions. However, the market faces limitations such as high costs of device implementation and maintenance, which can deter widespread adoption, coupled with concerns over data security and patient privacy. The regulatory landscape, with evolving standards, poses additional challenges for players in the sector. Innovation should be directed towards cost-effective solutions, refining device longevity, and enhancing data connectivity while ensuring robust cybersecurity measures. Companies should explore collaborations with tech firms to integrate AI for predictive analytics, offering a deeper understanding of patient data, which could reshape treatment pathways and establish new market benchmarks. Overall, the implantable cardiac monitor market is on a steady growth trajectory, driven by unmet clinical needs and propelled by technological progress, though with existing barriers that call for strategic industry responses.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Cardiac Monitor Market

The Implantable Cardiac Monitor Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiovascular disease
  • Growing preference for wearable cardiac devices
  • Increase in awareness about devices and treatment options for cardiac disorders
• Market Restraints
  • High initial cost associated with loop recorder
• Market Opportunities
  • Advancement in miniaturized implantable cardiac monitor with a long sensing vector
  • Technological developments in ICM technology for long-term ECG monitoring
• Market Challenges
  • Dearth of skilled professionals with expertise in electrocardiography

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Cardiac Monitor Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Cardiac Monitor Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Cardiac Monitor Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Cardiac Monitor Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Cardiac Monitor Market

A detailed market share analysis in the Implantable Cardiac Monitor Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Cardiac Monitor Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Cardiac Monitor Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Cardiac Monitor Market

A strategic analysis of the Implantable Cardiac Monitor Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Cardiac Monitor Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Angel Medical Systems, Inc., BioTelemetry, Inc. by Koninklijke Philips N.V., BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Jarvik Heart, Inc., LivaNova PLC, Medicomp, Inc., Medtronic PLC, Oracle Corporation, Phoenix Heart Center by Steward Medical Group, Preventice Solutions, Inc., Scott Fetzer Company, Siemens AG, and Techindia Infoway Pvt Ltd..

Market Segmentation & Coverage

This research report categorizes the Implantable Cardiac Monitor Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Indication, market is studied across Atrial Fibrillation, Cardiac Arrhythmias, and Epilepsy & Unexplained Falls.
• Based on Application, market is studied across Atrial Fibrillation and Syncope.
• Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers & Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiovascular disease
    • 5.1.1.2. Growing preference for wearable cardiac devices
    • 5.1.1.3. Increase in awareness about devices and treatment options for cardiac disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High initial cost associated with loop recorder
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancement in miniaturized implantable cardiac monitor with a long sensing vector
    • 5.1.3.2. Technological developments in ICM technology for long-term ECG monitoring
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled professionals with expertise in electrocardiography
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Implantable Cardiac Monitor Market, by Indication

• 6.1. Introduction
• 6.2. Atrial Fibrillation
• 6.3. Cardiac Arrhythmias
• 6.4. Epilepsy & Unexplained Falls

7. Implantable Cardiac Monitor Market, by Application

• 7.1. Introduction
• 7.2. Atrial Fibrillation
• 7.3. Syncope

8. Implantable Cardiac Monitor Market, by End User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Cardiac Centers & Clinics
• 8.4. Hospitals

9. Americas Implantable Cardiac Monitor Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Implantable Cardiac Monitor Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Implantable Cardiac Monitor Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Angel Medical Systems, Inc.
• 3. BioTelemetry, Inc. by Koninklijke Philips N.V.
• 4. BIOTRONIK SE & Co. KG
• 5. Boston Scientific Corporation
• 6. Jarvik Heart, Inc.
• 7. LivaNova PLC
• 8. Medicomp, Inc.
• 9. Medtronic PLC
• 10. Oracle Corporation
• 11. Phoenix Heart Center by Steward Medical Group
• 12. Preventice Solutions, Inc.
• 13. Scott Fetzer Company
• 14. Siemens AG
• 15. Techindia Infoway Pvt Ltd.